Tools to Guide Treatment Decisions in Breast Cancer

Mark Pegram, MD, and Lee Schwartzberg, MD, FACP, have a discussion on the management of early-stage hormone-receptor-positive breast cancer and the tools available to help inform treatment decisions.

EP. 1: The Evolution of Early-Stage HR+ Breast Cancer Management

August 5th 2022

Lee Schwartzberg, MD, FACP, and Mark Pegram, MD, discuss how the management of early-stage HR+ breast cancer has changed over time.

EP. 2: Measuring Ki-67 Levels to Inform HR+ Breast Cancer Treatment

August 5th 2022

Dr Lee Schwartzberg explains how Ki-67 is measured and used to inform management strategies for HR+ breast cancer at his clinical practice.

EP. 3: Updated Guidelines for the Management of HR+ Breast Cancer

August 12th 2022

Experts highlight some important and surprising updates in the ASCO [American Society of Clinical Oncology] guidelines for the management of HR+ breast cancer.

EP. 4: Recurrence Patterns in Early-Stage HR+ Breast Cancer

August 12th 2022

Drs Mark Pegram and Lee Schwartzberg examine late recurrence patterns in patients with HR+ breast cancer.